CJMB - callanjmb.com Long-Term Liabilities to Capital

Callan JMB Inc (CJMB) develops specialized medical equipment, with profitability gradually increasing as the clinical application of its products expands. This daily price chart reflects the asset's dynamics, where the indicator stands at 2.67. The business relies on robust agreements with clinics, which rarely switch suppliers due to the costs associated with retraining physicians. The constant supply of operating room consumables ensures a steady stream of profit for the company.

Callan JMB (CJMB): Long-Term Debt to Capital from 02/06/2025 to 10/28/2026

This ratio determines the company's dependence on long-term credit obligations relative to its equity. By analyzing long-term debt-to-equity, an investor assesses financial stability and the cost of borrowing. The metric reflects the balance between external financing and internal resources. For Callan JMB (CJMB), this serves as an indicator for scaling niche medical solutions. An increase in this figure may signal investments in equipment for surgical centers.

Competitor analysis

Long-Term Debt to Equity Ratio Intuitive Surgical, Inc.|Danaher Corp - Long-Term Debt to Capital|Long-Term Liabilities to Capital Becton Dickinson & Company (BDX)|STE - Long-Term Debt to Capital|Long-Term Debt to Capital Ratio westpharma.com WST|Long-Term Debt to Capital BAX (Baxter)|MASI - Ratio of Long-Term Indebtedness to Capital|STVN (Stevanato) - Long-Term Debt to Capital|Teleflex Corp (TFX) - Long-Term Debt to Equity Ratio|MMSI (Merit Medical Systems) - Long-Term Debt to Capital|Long-Term Debt to Capital NVST|Long-Term Debt to Equity ICU Medical (ICUI)|Long-Term Debt to Equity Dentsply Sirona Inc XRAY|Long-Term Debt to Equity Ratio LeMaitre|Long-Term Debt to Capital Coefficient AtriCure Medical ATRC|Long-Term Debt to Capital STAA (STAAR Surgical Company)|NAGE: Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity ZimVie|ANGO (AngioDynamics Inc) - Long-Term Debt to Capital Ratio|CERS: Long-Term Debt to Equity|Ratio of Long-Term Indebtedness to Capital Teknova Inc (TKNO)|Long-Term Debt to Equity Ratio Monogram Technologies|Long-Term Loans to Capital Ratio STSS (sharpstechnology.com)|Long-Term Debt to Equity InfuSystem Holdings, Inc.|UTMD - Long-Term Debt to Capital Coefficient|KORU Medical Systems Inc. - Long-Term Debt to Equity Ratio|NYXH: Long-Term Debt to Capital|MBOT (Microbot Medical Inc.) - Long-Term Debt to Equity|pro-dex.com (PDEX) - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital ZTEK (Zentek)|Long-Term Liabilities to Capital ELUT|Long-Term Debt to Equity Milestone Scientific Corp MLSS|Long-Term Debt to Capital Ratio NEXGEL Inc NXGL|Long-Term Debt to Equity Ratio Retractable Technologies, Inc. (RVP)|Harvard Bioscience Inc. - Long-Term Loans to Capital Ratio|Long-Term Debt to Equity FEMY (Femasys)|MHUA - Ratio of Long-Term Indebtedness to Capital|POAI (predictive-oncology.com) - Long-Term Debt to Capital|Atrion Corporation Inc. (ATRI) - Long-Term Debt to Equity Ratio|NURO (NeuroMetrix, Inc.) - Long-Term Debt to Capital